Product Information
CLORAZEPATE 3.75 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.6298 per EA under NDC 13107031905. Its NADAC has been published 223 times since Mar 23, 2022.
Strength
3.75 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107031905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLORAZEPATE DIPOTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA071858On Market Since
7/17/1987
Pharmacological Classes
Price Statistics
The NADAC for CLORAZEPATE 3.75 MG TABLET has been published 223 times since Mar 23, 2022, and over the history we have for it it has declined 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6298 per EA |
|---|---|
| All-time high | $1.3377 (Dec 14, 2022) |
| All-time low | $0.6005 (Jan 17, 2024) |
| 52-week high | $0.8878 |
| 52-week low | $0.6042 |
| Median price | $0.8375 |
| Average price | $0.8491 |
| Largest weekly change | +48.9% (Sep 18, 2024) |
| Weeks tracked | 223 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLORAZEPATE 3.75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLORAZEPATE 3.75 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.6298 per EA (NDC 13107031905), effective Jun 24, 2026.
How has the price of CLORAZEPATE 3.75 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLORAZEPATE 3.75 MG TABLET has declined 31.6%. It has been tracked across 223 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for CLORAZEPATE 3.75 MG TABLET?
Since Mar 23, 2022, the NADAC for CLORAZEPATE 3.75 MG TABLET has ranged from a low of $0.6005 (Jan 17, 2024) to a high of $1.3377 (Dec 14, 2022), with a median of $0.8375 per EA.
Are there cheaper alternatives to CLORAZEPATE 3.75 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CLORAZEPATE 3.75 MG TABLET, but none are currently priced below it.
Who manufactures CLORAZEPATE 3.75 MG TABLET?
CLORAZEPATE 3.75 MG TABLET (NDC 13107031905) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification